Survival of a Patient with Anaplastic Thyroid Cancer Following Intensity-modulated Radiotherapy and Sunitinib - A Case Report

被引:0
|
作者
Schoenfeld, Jonathan D. [1 ,3 ]
Odejide, Oreofe O. [2 ,4 ]
Wirth, Lori J. [2 ]
Chan, Annie W. [1 ]
机构
[1] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Radiat Oncol, Boston, MA 02114 USA
[2] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med Oncol, Boston, MA 02114 USA
[3] Harvard Radiat Oncol Program, Boston, MA USA
[4] Dana Farber Partners CancerCare Hematol Oncol Fel, Boston, MA USA
关键词
Anaplastic thyroid carcinoma; chemoradiation; intensity-modulated radiation therapy (IMRT); sunitinib; case report; PROGNOSTIC-FACTORS; TREATMENT OUTCOMES; PHASE-II; CARCINOMA; SURGERY; TRIAL; RADIATION;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Anaplastic: thyroid cancer has a very poor prognosis, especially in patients who have gross residual disease following resection. Case Report: We present the case of a patient with anaplastic thyroid cancer and a significant gross residual disease treated with intensity-modulated radiotherapy with concurrent chemotherapy and sunitinib who had a complete response and remains without evidence of disease more than 18 months after diagnosis. Conclusion: Chemoradiotherapy has an important role in the adjuvant treatment of anaplastic thyroid cancer in selected patients and should be considered when gross residual disease is present following resection. The combined use of radiotherapy and targeted biological agents such as sunitinib may warrant further investigation.
引用
收藏
页码:1743 / 1746
页数:4
相关论文
共 50 条
  • [21] Radiological and clinical results following high-dose intensity-modulated radiotherapy in recurrent craniopharyngioma: A case report
    Pierro, Antonio
    Cilla, Savino
    Picardi, Vincenzo
    Ferro, Marica
    Macchia, Gabriella
    Deodato, Francesco
    Buwenge, Milly
    Sallustio, Giuseppina
    Morganti, Alessio G.
    ONCOLOGY LETTERS, 2015, 10 (04) : 2491 - 2494
  • [22] Feasibility of intensity-modulated radiotherapy to treat gastric cancer
    Skrobala, Agnieszka
    Adamczyk, Marta
    Karczewska-Dzionk, Aldona
    REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2019, 24 (01) : 68 - 73
  • [23] Clinical evaluation of intensity-modulated radiotherapy for locally advanced pancreatic cancer
    Goto, Yoko
    Nakamura, Akira
    Ashida, Ryo
    Sakanaka, Katsuyuki
    Itasaka, Satoshi
    Shibuya, Keiko
    Matsumoto, Shigemi
    Kanai, Masashi
    Isoda, Hiroyoshi
    Masui, Toshihiko
    Kodama, Yuzo
    Takaori, Kyoichi
    Hiraoka, Masahiro
    Mizowaki, Takashi
    RADIATION ONCOLOGY, 2018, 13
  • [24] Postoperative pelvic intensity-modulated radiotherapy in high risk endometrial cancer
    Shih, Karin K.
    Milgrom, Sarah A.
    Abu-Rustum, Nadeem R.
    Kollmeier, Marisa A.
    Gardner, Ginger J.
    Tew, William P.
    Barakat, Richard R.
    Alektiar, Kaled M.
    GYNECOLOGIC ONCOLOGY, 2013, 128 (03) : 535 - 539
  • [25] Proposed genitalia contouring guidelines in anal cancer intensity-modulated radiotherapy
    Brooks, C.
    Hansen, V. N.
    Riddell, A.
    Harris, V. A.
    Tait, D. M.
    BRITISH JOURNAL OF RADIOLOGY, 2015, 88 (1051)
  • [26] Biological intensity-modulated radiotherapy plus neoadjuvant chemotherapy for multiple peritoneal metastases of ovarian cancer: A case report
    Huang, Shigao
    Dang, Yazheng
    Li, Fujun
    Wei, Wei
    Ma, Yuxin
    Qiao, Song
    Wang, Qianyun
    ONCOLOGY LETTERS, 2015, 9 (03) : 1239 - 1243
  • [27] Application of intensity-modulated radiotherapy in unresectable poorly differentiated thyroid carcinoma
    Xue, Fen
    Li, Duanshu
    Hu, Chaosu
    Wang, Zhuoying
    He, Xiayun
    Wu, Yi
    ONCOTARGET, 2017, 8 (09) : 15934 - 15942
  • [28] Organ-sparing Intensity-modulated Radiotherapy for Anal Cancer using the ACTII Schedule: A Comparison of Conventional and Intensity-modulated Radiotherapy Plans
    Brooks, C. J.
    Lee, Y. K.
    Aitken, K.
    Hansen, V. N.
    Tait, D. M.
    Hawkins, M. A.
    CLINICAL ONCOLOGY, 2013, 25 (03) : 155 - 161
  • [29] Treatment outcome of anaplastic ependymoma under the age of 3 treated by intensity-modulated radiotherapy
    Lee, Joongyo
    Chung, Seung Yeun
    Han, Jung Woo
    Kim, Dong-Seok
    Kim, Jina
    Moon, Jin Young
    Yoon, Hong In
    Suh, Chang-Ok
    RADIATION ONCOLOGY JOURNAL, 2020, 38 (01): : 26 - 34
  • [30] Intensity-modulated radiotherapy in head and neck cancer: Ethics and methodology
    Lapeyre, M.
    Biau, J.
    Miroir, J.
    Servagi-Vernat, S.
    Giraud, P.
    CANCER RADIOTHERAPIE, 2014, 18 (5-6): : 365 - 368